Leadership & Pay ·
Faeth Therapeutics, Inc. (formerly Sensei Biotherapeutics, Inc.) announced a name change and a new trading symbol…
SNSESensei Biotherapeutics, Inc.
Faeth Therapeutics, Inc. (formerly Sensei Biotherapeutics, Inc.) announced a name change and a new trading symbol, FTH, effective June 15, 2026. The company also announced several leadership changes, including the appointment of Anand Parikh as President and CEO, Brian Stephenson as CFO, and Josiah Craver as Senior VP of Finance. Additionally, the company terminated a $50 million sales agreement with Jefferies LLC. Faeth Therapeutics, Inc. is a biotechnology company focused on developing therapeutic solutions for cancer and other diseases.